Angiotensin II-induced stimulation of smooth muscle α-actin expression by serum response factor and the homeodomain transcription factor MHox

Circulation Research

Volumn 81, Issue 4, 1997, Pages 600-610

  Hautmann, Martina B ^a   Thompson, Maria M ^a   Swartz, Ellen A ^a   Olson, Eric N ^b   Owens, Gary K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; MHox; Smooth muscle actin promoter; Vascular smooth muscle cell

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0030862962     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.4.600     Document Type: Article

References (77)

1. Aalkjaer C, Eiskjaer H, Mulvany MJ, Jespersen B, Kjaer T, Sorensen SS, Pedersen EB. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens. 1987;7: 305-310.
2. Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A, the Groupe de Prevention Cardio-Vasculaire en Medecine du Travail, Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension. 1993;22:111-118.
3. Owens G. Differential effects of antihypertensive therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res. 1985;56: 525-536.
4. Owens GK. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol. 1989;257:H175-H1765.
5. Sehelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens. 1991;9:3-15.
6. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats, Hypertension. 1987;9:178-187.
7. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res. 1983; 53:491-501.
8. Mulvany MJ, Baandrup U, Gundersen HJ. Evidence for hyperplasia in mescnteric resistance vessels of spontaneously hypertensive rats using a three-dimensional dissector. Circ Res. 1985;57: 794-800.
9. Owens GK, Schwartz SM, McCanna M. Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats. Hypertension. 1988;11:198-207.
10. Freslon J, Giudiceili J. Compared myocardial and vascular eftects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol. 1983;80:533-543.
11. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-635.
12. Azumna H, Niimi Y, Hamasaki H. Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br J Pharmacol. 1989;106:65-671.
13. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
14. Berk BC, Vekshtein V, Gordon H, Tsuda T. Angiotensin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertnsion. 1989;13:305-314.
15. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and e-myc gene expression by angiotensin II in cultured rat vascular smooth muscle. J Clin Invest. 1989;83: 1419-1424.
16. Hershey JC, Hautmann M, Thompson MM. Rothblum LI, Haystead TAJ, Owens GK. Angiotensin II-induced hypertrophy of rat vascular smooth muscle cells is associated with increased 18S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor. J Biol Chem. 1995;270:25096-25101.
17. Voit R, Schnapp A, Kuhn A, Rosenbauer H, Hirsehmann P, Stunnenberg HG, Grummt J. The nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the C-terminal hyperacidic tail which is essential for transcription. EMBO J. 1992;11:2211-2218.
18. O'Mahony DJ, Smith SD, Xie W, Rothblum LJ. Analysis of the phosphorylation, DNA-binding and dimerization properties of the RNA polymerase I transcription factor UBF1 and UBF2. Nucleic Acids Res. 1992;20:1301-1308.
19. O'Mahony DJ, Xie W, Smith SD, Singer HA, Rothblum LI. Differential phosphorylation and localization of the transcription factor UBF in vivo in response to serum deprivation: in vitro dephosphorylation of DBF reduces its transactivation properties. J Biol Chem. 1992;267:35-38.
20. Fleurent M, Gingras A-C. Sonenberg N, Meloche S. Angiotensin II stimulates phosphorylation of the translational repressor 4H-binding protein 1 by a mitogen-activated protein kinase-independent mechanism. J Biol Chem. 1997;272:4006-4012.
21. Rao GN, Griendling KK, Frederickson RM, Sonenberg N, Alexander RW. Angiotensin II induces phosphorylation of eukaryotic protein synthesis initiation factor 4E in vascular smooth muscle cells. J Biol Chem. 1994;269:7180-7184.
22. Turla MB, Thompson MM, Corjay MM, Owens GK. Mechanisms of angiotensin II-and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells: evidence for selective increases in smooth muscle isoactin expression. Circ Res. 1991;68:288-299.
23. Owens GK, Rabinovitch PS, Schwartz SM. Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A. 1981;78:7759-7763.
24. Shimizu RT, Blank RS, Jervis R, Lawrenz-Smith SC, Owens GK. The smooth muscle α-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem. 1995;270:7631-7643.
25. Chow KL, Schwartz RJ. A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene. Mol Cell Biol. 1990;10: 528-538.
26. Gustafson TA, Miwa T, Boxer LM, Kedes L. Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac alpha-actin promoter. Mol Cell Biol. 1988;8:4110-4119.
27. Muscat GE, Kedes L. Multiple 5′-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression. Mol Cell Biol. 1987;7:4089-4099.
28. Mohun TJ, Taylor MV, Garrett N, Gurdon JB. The CArG promoter sequence is necessary for muscle-specific transcription of the cardiac actin gene in Xenopus embryos. EMBO J. 1989;8: 1153-1161.
29. Papadopoulos N, Crow MT. Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cisacting DNA elements and binding of serum response factor. Mol Cell Biol. 1993;13:6907-6918.
30. Kharbanda S, Rubin E, Datta R, Hass R, Sukhatme V, Kufe D. Transcriptional regulation of the early growth response 1 gene in human myeloid leukemia cells by okadaic acid. Cell Growth Differ. 1993;4:17-23.
31. Hautmann MB, Raines DP, Owens GK. Transforming growth factor β1 coordinately upregulates expression of smooth muscle cell specific differentiation markers. In: The Molecular Biology of the Cardiovascular System Keystone Symposia; January, 1996; Keystone, Colo. Abstract 124.
32. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74: 5463-5467.
33. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening reeombinant plasmid DNA. Nucleic Acids Res. 1979;7: 1513-1523.
34. Monical PL, Owens GK, Murphy RA. Expression of myosin regulatory light-chain isoforms and regulation of phosphorylation in smooth muscle. Am J Physiol. 1993;264:C1466-C1472.
35. Corjay MH, Thompson MM, Lynch KR, Owens GK. Differential effect of PDGF-versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin inRNA expression in cultured rat aortic smooth muscle cells. J Biol Chem. 1989;264: 10501-10506.
36. Blank RS, Owens GK. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J Cell Physiol. 1990;142:635-642.
37. Pothier F, Ouellet M, Julien J-P, Guérin SL. An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol. 1992;11:83-90.
38. Seed B, Sheen JY. A simple phase-extraction assay for chloramphenicol acetyltransferase activity, Gene. 1988;67:271-277.
39. Corjay MH, Blank RS, Owens GK. Platelet-derived growth factor-induced destuhilization of smooth muscle alpha-actin mRNA. J Cell Physiol. 1990;145:391-397.
40. Schwarzbauer JE, Tamkun JW, Lemischka JR, Hynes RO. Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell. 1983;35:421-431.
41. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984;81:1991-1995.
42. Wilson GN, Hollar BA, Waterson JR, Schmickel RD. Molecular analysis of cloned human 18S ribosomal DNA segments. proc Natl Acad Sci U S A. 1978;75:5367-5371.
43. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
44. Norman C, Runswick M, Pollock R, Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 1988;55: 989-1003.
45. Cserjesi P, Lilly B, Bryson L, Wang Y, Sassoon DA, Olson EN. MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development, 1992;115:1087-1101.
46. Chakraborty T, Brennan TJ, Li L, Edmondson D, Olson EN. Inefficient homo-oligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding. Mol Cell Biol. 1991;11:3633-3641.
47. Lee T-C, Shi Y, Schwartz RJ. Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal α-actin transcription in embryonic myoblasts. Proc Natl Acad Sci U S A. 1992; 89:9814-9818.
48. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor β(TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J Biol Client. 1997;272:10948-10959.
49. Hill CS, Marais R, John S, Wynnes J, Dalton S, Treisman R. Functional analysis of a growth factor-responsive transcription factor complex. Cell. 1993;73:395-406.
50. Dalton S, Treisman R. Characterization of SAP-1, a protein recruited by scrum response factor to the c-fos serum response element. Cell. 1992;68:597-612.
51. Blank RS, Swartz EA, Thompson MM, Olson EN, Owens GK. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ Res. 1995;76:742-749.
52. Grueneberg DA, Natesan S, Alexandre C, Gilman MZ. Human and drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science. 1992;257:1089-1095.
53. Grueneberg DA, Simon KJ, Brennan K, Gilman M. Sequence-specific targeting of nuclear signal transduction pathways by homeodomain proteins. Mol Cell Biol. 1995;15:3318-3326.
54. I,-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. J Biol Chem. 1995;270:410-417.
55. McLellan WR, Lee T-C, Schwartz RJ, Schneider MD. Transforming growth factor-β response elements of the skeletal α-actin gene. J Biol Chem. 1994;269:16754-16760.
56. Van Putten V, Li X, Maselli J, Nemenoff RA. Regulation of smooth muscle α-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells. Circ Res. 1994;75:1126-1130.
57. Andrawis NS, Ruley EH, Aberneth DR. Angiotensin II regulates human vascular smooth muscle α-actin gene expression. Biochem Biophys Res Commun. 1993;196:962-968.
58. Blank RS, McQuinn TC, Yin KC, Thompson MM, Takeyasu K, Schwartz RJ, Owens GK. Elements of the smooth muscle α-actin promoter required in cis for transcriptional activation in smooth muscle. J Biol Client. 1992;267:984-989.
59. + exchange and intracellular pH. J Biol Client. 1990;265:19632-19637.
60. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen R-H, Blenis J, Greenberg ME. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol Cell Biol. 1993;13:6260-6273.
61. Croissant JD, Kim J-H, Eichele G, Goering L, Lough J, Prywes R, Schwartz RJ. Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev Biol. 1996;177:250-264.
62. Kim J-H, Johansen F-E. Robortson N, Catino JJ, Prywes R, Kumar CC. Suppression of ras transformation by serum response factor. J Biol Chem. 1994;269:13740-13743.
63. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev. 1994;4:96-101.
64. Chen CY, Schwartz RJ. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac α-actin gene transcription. Mol Cell Biol. 1996;16:6372-6384.
65. Madsen CS, Hershey JC, Hautmann MB, White SL, Owens GK. Expression of the smooth muscle myosin heavy chain gene is regulated hy a negative-acting GC-rich element located between two positive-acting CArG boxes. J Biol Chem. 1997;272:6332-6340.
66. Li L, Miami JM, Mercer B, Olson EN. Expression of the SM22 alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory proarams in vascular and visceral smooth muscle cells. J Cell Biol. 1996;132:849-859.
67. Herring BP, Smith AF. Telokin expression is mediated by a smooth muscle cell-specific promoter. Am J Physiol. 1996;270:C1656-C1665.
68. Yano H, Hayashi K, Momiyama T, Saga H, Haruna M, Sobne K. Transcriptional regulation of the chicken caldesmon gene: activation of gizzard-type caldesmon promoter requires a CArG box-like motif, J Biol Chem. 1995;270:23661-23666.
69. Simeone A, Acampora D, Nigro V, Faiella A, D'Esposito M, Stornaiuolo A, Mavilio F, Boncinelli E. Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells. Mech Dev. 1991;33:215-227.
70. Sartorelli V, Webster KA, Kedes L. Muscle-specific expression of the cardiac α-actin gene requires Myo D1, CArG-box binding factor and Sp1. Genes Dev. 1990;4:1811-1822.
71. Hill CS, Wynne J. Treisman R. The Rho family GTPases Rho A, Rac 1, and CDC42Hs legulate transcriptional activation by SRF. Cell. 1995;81:l159-1170.
72. I-adrenergic receptor signaling in cardiomyocytes. J Biol Chem. 1996;271:31185-31190.
73. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: amocrine transforming growth factor expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
74. Björkerud S. Effects of transforming growth factor-β 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb. 1991;11:892-902.
75. Desmouliere A, Geinoz A, Gabbiani G. Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.
76. Verbeck MM, Otte-Holler J, Wesseling P, Ruiter DJ, de Waal RM. Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol. 1994;144:372-382.
77. Stouffer GA, Shimizu RT, Turla MB, Owens GK. Ang II- or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. Am J Physiol. 1993;264:C390-C395.